LEXINGTON, Mass., March 28, 2012 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 11th annual Needham Healthcare Conference at 9:20 a.m. ET on April 4, 2012, in New York City.
